Philadelphia, PA – Neuralert Technologies LLC (www.neuralerttechnologies.com) was one of eight startups from the U.S. and Canada selected for the latest iteration of University City Science Center Launch Lane Accelerator. This is the fifth cohort for Launch Lane (formerly the Digital Health Accelerator (DHA)). Launch Lane focuses on the equitable sourcing of companies, with the selection process utilizing a blind application to eliminate biases.
Neuralert is a spin-out from the University of Pennsylvania, founded by Steven Messe, MD (Department of Neurology) and James Weimer, PhD (Department of Computer and Information Science). The company’s novel invention addresses the problem of late or undetected stroke in hospitalized patients. The system uses non-invasive, wearable devices which accurately detect stroke symptoms and then alerts clinical staff to more rapidly initiate stroke mitigating treatments. Neuralert decreases stroke detection time by over 400% compared to the current standard of care saving patient lives, improving outcomes, and reducing hospital costs and liability.
“Currently, hospital stroke detection requires consistent, timely, and effective manual assessment. Unfortunately, the majority of in-hospital strokes are not detected in a timely manner resulting in treatment delays which adversely impacts patient outcomes and hospital cost” said Eric Corkhill. CEO of Neuralert. “Neuralert is an automated stroke detection system which constantly monitors the patient for stroke-based asymmetry, a revolutionary change in managing stroke. Funding from the Science Center’s Launch Lane Accelerator will significantly help us to operationalize the product. In addition to their investment, I look forward to participating programming tailored to our growth needs and access to the Science Center’s vast network of connections and resources.”
